Status:
UNKNOWN
Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback
Lead Sponsor:
ETH Zurich
Collaborating Sponsors:
Swiss Epilepsy Centre - Klinik Lengg
Conditions:
Psychogenic Seizure
Epilepsy, Temporal Lobe
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study investigates whether the sense of agency is sensitive to self-regulation by means of EEG-based neurofeedback. During neurofeedback, the brain activity in response to a motor task is recorde...
Eligibility Criteria
Inclusion
- Inclusion Criteria (all):
- Aged \> 18 years old
- Normal or corrected-to-normal visual acuity
- Willing to participate in the study (by signing the informed consent form)
- Neither caffein, nor alcohol intake 48 hours prior to the experiment
- Regular intake of drugs (except oral contraceptives in women)
- Employed by, or in a dependent relationship with, the sponsor and / or the investigator(s)
- Sufficient knowledge of German or English to understand study documents and instructions.
- Inclusion Criteria (patients):
- A diagnosis of temporal epilepsy (TE), documented via video EEG. OR
- A diagnosis of psychogenic non-epileptic seizure (PNES), according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and documented via video EEG.
- Exclusion Criteria (all):
- Past surgery in the brain
- History of alcohol or drug abuse
- Incompatibility with EEG recordings, e.g., inability to stay seated for 90 minutes.
Exclusion
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2025
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT05214833
Start Date
February 1 2022
End Date
January 31 2025
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ETH Zurich
Zurich, Canton of Zurich, Switzerland, 8057